VAERS reports by lot

GSK Varicella/Shingles lot 73PP9: VAERS reports

31 VAERS reports list lot 73PP9 as a GSK Varicella/Shingles vaccine, received between 2023-02-07 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4341%
General / Systemic (non-local)1918%
Neurological1111%
Dermatological (non-injection-site)1010%
Gastrointestinal66%
Allergic / Anaphylactic55%
Musculoskeletal55%
Psychiatric / Neuropsychiatric33%
Cardiac / Cardiovascular11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
North Carolina4
New York3
Washington3
Virginia2
New Hampshire2
Georgia2
Maryland2
Oregon2
South Carolina2
Pennsylvania1
Indiana1

Reports by month received

2023-024
2023-0311
2023-041
2023-055
2023-061
2023-083
2024-066

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.